Prucalopride succinate

Prucalopride Succinate is the succinate salt form of prucalopride, an orally bioavailable dihydro-benzofuran-carboxamide and selective serotonin (5-HT4) receptor agonist, with gastrointestinal (GI) prokinetic activity. Upon oral administration, prucalopride specifically targets, binds to and stimulates the 5-HT4 receptor. This alters colonic motility patterns and stimulates colonic mass movements. This may normalize bowel movements and may relief chronic constipation. Additionally, by increasing esophageal and gastric motility, prucalopride may also provide relief for aspiration-associated symptoms. It is grouped under the following drug class(es): Prokinetic agents. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Motegrity and Resotran. Its PubChem CID is 9870009.

CAS No 179474-85-2
Molecular Formula C22H32ClN3O7
Molecular Weight 486.0 g/mol
Synonyms 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide;butanedioic acid

Frequently Asked Questions